GLP-1RA can also be utilized to treat polycystic ovarian syndrome (PCOS) by increasing hyperandrogenaemia and associated metabolic parameters
Vitamin C is essential for collagen synthesis, immune support, and overall health
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
Originally approved for diabetes, GLP-1 drugs are positively used in the management of weight loss, cardiovascular risk, fatty liver disease, and neurodegenerative conditions
The mechanism of action involves several physiological pathways that contribute to both glycemic control and weight loss
This is a remarkable finding for a biologically active compound